Seeing Is Believing
Currently out of the existing stock ratings of Jason Mills, 159 are a BUY (83.68%), 28 are a HOLD (14.74%), 3 are a SELL (1.58%).
Analyst Jason Mills works with a stock forecast success ratio of 80.78% fulfilled within 197.05 days on average. Previously, Jason Mills worked at CANACCORD.
Jason Mills’s has documented 365 price targets and ratings displayed on 21 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on PEN, Penumbra at 21-Dec-2023.
Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for VAPO (VAPOTHERM) at 3/5/2020. The price target of $112 was fulfilled within 11 days with a profit of $30.8 (37.93%) receiving and performance score of 34.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
77
$8.38 (12.21%)
65
21 days ago
15/16 (93.75%)
$9.18 (13.54%)
483
Buy
71
$2.38 (3.47%)
63
1 months 27 days ago
11/12 (91.67%)
$6.18 (9.53%)
341
Buy
80
$11.38 (16.58%)
60
1 months 27 days ago
3/4 (75%)
$15.18 (23.42%)
110
Buy
72
$3.38 (4.93%)
55
1 months 27 days ago
2/3 (66.67%)
$7.18 (11.08%)
798
Buy
71
$2.38 (3.47%)
60
1 months 27 days ago
19/20 (95%)
$6.18 (9.53%)
331
Which stock is Jason Mills is most bullish on?
Which stock is Jason Mills is most reserved on?
What Year was the first public recommendation made by Jason Mills?